ARTICLE | Discovery & Translation
BioCentury’s roundup of translational innovation also features a kinase degrader for breast cancer, and half a dozen papers on product candidates
By Danielle Golovin, Senior Biopharma Analyst
December 5, 2024 12:01 AM UTC
A pair of studies by independent groups revealed advances in respiratory syncytial virus (RSV) and human metapneumovirus (hMVP) vaccines.
In the first study, published in Nature Microbiology, Johnson & Johnson (NYSE:JNJ) developed an RSV vaccine that prevents lower respiratory tract infections similar to current RSV vaccines, but without inducing potentially problematic antibodies against a vaccine design component…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654338/science-spotlight-advances-in-rsv-and-hmvp-vaccines